Estrogen's potential impact on chemoresistance in high-grade serous ovarian cancer

被引：0
|
作者：
Marolt, N. [1 ]
Pavlic, R. [1 ]
Gjorgoska, M. [1 ]
Kreft, T. [1 ]
Rizner, T. Lanisnik [1 ]
机构：
[1] Univ Ljubljana, Fac Med, SI-1000 Ljubljana, Slovenia
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-081
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [21] Frizzled 6 endows high-grade serous ovarian cancer with stem-like properties and chemoresistance
    Chen, Shaorong
    Yang, Guang
    Shi, Qirong
    Wan, Ningning
    Lin, Ruyin
    Wang, Lianhua
    Hu, Xinxin
    Zhuang, Xuanxuan
    Yu, Liying
    Sui, Ming
    MOLECULAR CARCINOGENESIS, 2024, 63 (10) : 2001 - 2012
  • [22] Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
    Feng, Li-yuan
    Yan, Bing-bing
    Huang, Yong-zhi
    Li, Li
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [23] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [24] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer
    Norris, E. J.
    DeStephanis, D.
    Zhang, Q.
    Tait, D. L.
    Ganapathi, R.
    Ganapathi, M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 71 - 71
  • [25] Investigating NKAPL, a potential marker for platinum resistance, in high-grade serous ovarian cancer
    Schafer, Lea
    Silva, Romina
    Stewart, Gavin
    O'Toole, Sharon
    Perry, Antoinette
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A92 - A93
  • [26] Evaluating the impact of a history of breast cancer on outcomes in women with high-grade serous ovarian cancer
    Gillen, J.
    Rowland, M.
    Liu, A. Y.
    Vesely, S.
    Powell, B.
    Blank, S. V.
    Krutz, M.
    Frey, M. K.
    Freeman, J.
    Cass, I.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 212 - 212
  • [27] Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer
    Bachmayr-Heyda, Anna
    Aust, Stefanie
    Auer, Katharina
    Meier, Samuel M.
    Schmetterer, Klaus G.
    Dekan, Sabine
    Gerner, Christopher
    Pils, Dietmar
    CLINICAL CANCER RESEARCH, 2017, 23 (08) : 2081 - 2092
  • [28] IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Aust, S.
    Bachmayr-Heyda, A.
    Auer, K.
    Meier, S.
    Schmetterer, K.
    Dekan, S.
    Gerner, C.
    Pils, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1798 - 1798
  • [29] Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer (HGSOC)
    LaVigne, K.
    Benhamida, J.
    Young, J.
    Zivanovic, O.
    Chi, D. S.
    Snyder, A.
    Hollmann, T.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 76 - 76
  • [30] IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Aust, S.
    Bachmayr-Heyda, A.
    Auer, K.
    Meier, S.
    Schmetterer, K.
    Dekan, S.
    Gerner, C.
    Pils, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 335 - 335
12345